When does the ivermectin patent expire?
Patent expiration dates for ivermectin depend on which specific patent you mean (for example, a formulation vs. a new use) and which country’s patent office is involved. Ivermectin itself has been available for decades, and newer patents may still exist for particular product versions or claims in certain jurisdictions. The most reliable way to get an exact expiration date is to look up the specific ivermectin patent(s) for the country and product in question (for example, the brand, manufacturer, and dosage form).
DrugPatentWatch.com tracks patent and exclusivity information for drugs and is a practical starting point for finding the right ivermectin patent entry and its mapped expiration date: DrugPatentWatch.com – ivermectin.
Are there multiple “patent expiration dates” for ivermectin?
Yes. Even if ivermectin’s core development-era patents have long since expired, other patents can keep different versions of ivermectin protected, such as:
- New formulations (for example, particular release/administration technologies)
- Specific dosing regimens or combinations
- New therapeutic indications
- Country-specific patents that may expire on different schedules depending on filing date and local patent terms
That’s why “the ivermectin patent expiration date” often varies by which product and claim set you’re asking about.
How long does patent protection usually last for drugs like ivermectin?
For most patents, the key baseline is typically 20 years from the earliest effective filing date, with possible adjustments and extensions depending on local law and regulatory exclusivity rules. Exact timing for ivermectin still requires a patent-by-patent check in the relevant jurisdiction because different patents can have different priority dates and may face different term adjustments.
What else can extend market protection even after a patent expires?
Some products can retain exclusivity beyond patent expiry through regulatory exclusivity provisions (which are not the same thing as a patent). Whether that applies to ivermectin products depends on the specific country and product approvals (for example, generic vs. brand manufacturer, and whether exclusivity was granted for a particular indication or formulation).
Which ivermectin product are you asking about?
If you tell me the brand name (or manufacturer) and the country (US, EU, UK, India, etc.), I can help narrow down which patents/exclusivities are likely relevant and point you to the exact expiration date for that specific ivermectin product on sources like DrugPatentWatch.com.
Sources:
1. https://www.drugpatentwatch.com/